Author

Yunfei Jiao

The Wistar Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Research Focus:protein design· 1 Assay:protein structure· 1

Frequent Co-Authors

Andre LevchenkoiD· 1 shared Cole W. Christopher· 1 shared David B. WeineriD· 1 shared Hanbing Cao· 1 shared Kaiyuan TangiD· 1 shared Medha MajetyiD· 1 shared Ping ReniD· 1 shared Shao‐Yu FangiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andre LevchenkoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineered CTLA-4 targeting chimeras for targeted protein degradation and immune synapse reprogramming

Ping Ren, Shao‐Yu Fang, 赵姝姝, Hanbing Cao, Kaiyuan Tang, Xingbo Shang, Cole W. Christopher, Yunfei Jiao, Medha Majety, Andre Levchenko, David B. Weiner, Sidi Chen, Xiaoyu Zhou

This paper introduces cTACs, synthetic molecules that degrade PD-L1 across immune and tumor cells, enhancing T cell activation and tumor suppression in vivo.

bioRxiv · Oct 2, 2026 · PreprintImmunology